Get the Stockscreener App
5.33
3.70%
0.19
Olema Pharmaceuticals Inc stock is traded at $5.33, with a volume of 707.25K.
It is up +3.70% in the last 24 hours and up +21.97% over the past month.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
See More
Previous Close:
$5.14
Open:
$5.09
24h Volume:
707.25K
Relative Volume:
0.97
Market Cap:
$364.69M
Revenue:
-
Net Income/Loss:
$-96.66M
P/E Ratio:
-2.4791
EPS:
-2.15
Net Cash Flow:
$-83.73M
1W Performance:
+13.16%
1M Performance:
+21.97%
6M Performance:
-12.77%
1Y Performance:
-67.62%
1-Day Range:
$4.97
$5.40
1-Week Range:
$4.70
$5.40
52-Week Range:
$2.86
$14.41
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Name
Olema Pharmaceuticals Inc
Sector
Industry
Phone
(415) 651-3316
Address
780 BRANNAN STREET, SAN FRANCISCO
Compare OLMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
5.33 | 351.69M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-02-24 | Initiated | Goldman | Buy |
| Jan-30-24 | Initiated | Citigroup | Buy |
| Jul-21-23 | Initiated | Oppenheimer | Outperform |
| May-05-23 | Initiated | CapitalOne | Overweight |
| Feb-22-23 | Initiated | Credit Suisse | Outperform |
| Jul-06-22 | Resumed | Canaccord Genuity | Buy |
| Jun-09-22 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-28-22 | Initiated | H.C. Wainwright | Neutral |
| Dec-07-21 | Resumed | Cowen | Outperform |
| Dec-14-20 | Initiated | Canaccord Genuity | Buy |
| Dec-14-20 | Initiated | Cowen | Outperform |
| Dec-14-20 | Initiated | JP Morgan | Overweight |
| Dec-14-20 | Initiated | Jefferies | Buy |
View All
Olema Pharmaceuticals Inc Stock (OLMA) Latest News
Understanding Olema Pharmaceuticals Inc.’s price movementCapital Growth Plan for New Investors - Newser
How to integrate Olema Pharmaceuticals Inc. into portfolio analysis toolsTechnical Setup Guide for Daily Watchlist - Newser
How hedge fund analytics apply to Olema Pharmaceuticals Inc. stockPrice Forecast Based on AI Analysis - Newser
How Interest Rate Changes Impact Olema Pharmaceuticals Inc. Stock PerformanceWeekly Price Target Forecast and Alerts - Newser
Is a relief rally coming for Olema Pharmaceuticals Inc. holdersAI Trading Forecast Based on Big Data - Newser
What makes Olema Pharmaceuticals Inc. stock price move sharplyConservative Investment Setup and Risk Analysis - Newser
Can a trend reversal in Olema Pharmaceuticals Inc. lead to recoveryFree Pattern Breakout Entry Stock Forecast - Newser
How does Olema Pharmaceuticals Inc. generate profit in a changing economyMarket Forecast Data Feed Backed By Experts - jammulinksnews.com
Olema Pharmaceuticals Inc. stock volume spike explainedFree Real Market Momentum Signal Generator - Newser
Backtesting results for Olema Pharmaceuticals Inc. trading strategiesDay Trading Plan with Entry Risk Management - Newser
Advanced analytics toolkit walkthrough for Olema Pharmaceuticals Inc.Free Risk-Adjusted Picks With Exit Strategy - Newser
Published on: 2025-07-31 19:37:23 - Newser
Combining price and volume data for Olema Pharmaceuticals Inc.Technical Safety Zone Pattern Recognition - Newser
Olema Pharmaceuticals (OLMA) to Release Quarterly Earnings on Tuesday - MarketBeat
Olema Pharmaceuticals Inc. stock trend forecastDeep Stock Performance and Volatility Analysis - Newser
Key metrics from Olema Pharmaceuticals Inc.’s quarterly dataTrade Setup Builder with Custom Alerts - Newser
How institutional ownership impacts Olema Pharmaceuticals Inc. stockAI Powered Buy Point Forecast Planner - Newser
How volatile is Olema Pharmaceuticals Inc. stock compared to the marketEarnings Report Alerts For Every Investor - jammulinksnews.com
Shareholders Can't Ignore US$1.9m Of Sales By Olema Pharmaceuticals Insiders - simplywall.st
Is Olema Pharmaceuticals Inc. stock overvalued or undervaluedTop Growth Planner That Work - jammulinksnews.com
What catalysts could drive Olema Pharmaceuticals Inc. stock higher in 2025Unlock powerful trading strategies for gains - jammulinksnews.com
How does Olema Pharmaceuticals Inc. compare to its industry peersEarnings Report Alerts For Every Investor - jammulinksnews.com
Does Olema Pharmaceuticals Inc. stock perform well during market downturnsSkyrocketing returns - jammulinksnews.com
What is the risk reward ratio of investing in Olema Pharmaceuticals Inc. stockEarnings Report Strategy With High Returns - jammulinksnews.com
Olema Pharmaceuticals Inc. stock trend forecast Free High Return Stock Focus With Safety - Newser
What are the latest earnings results for Olema Pharmaceuticals Inc.Achieve rapid financial growth with expert help - jammulinksnews.com
Is a relief rally coming for Olema Pharmaceuticals Inc. holders Free Stock Screener With Smart Filters - metal.it
What are Olema Pharmaceuticals Inc. company’s key revenue driversBuild a diversified portfolio for steady growth - jammulinksnews.com
Olema Pharmaceuticals Inc. Stock Support and Resistance Levels You Should KnowFree Stock Trading Signals - Newser
Is Olema Pharmaceuticals Inc. a good long term investmentFree Investment Case Studies - PrintWeekIndia
What analysts say about Olema Pharmaceuticals Inc. stockConsistently outstanding ROI - Autocar Professional
Olema Pharmaceuticals Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - jammulinksnews.com
Olema Pharmaceuticals Inc Stock (OLMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):